Scopus
🔓 Açık Erişim YÖKSİS Eşleşti
Matrix metalloproteinases 2 and 9 activity after intra-articular injection of autologous platelet-rich plasma for the treatment of osteoarthritis in dogs
Acta Veterinaria Brno · Ocak 2018
YÖKSİS Kayıtları
Matrix metalloproteinases 2 and 9 activity after intra-articular injection of autologous platelet-rich plasma for the treatment of osteoarthritis in dogs
Acta Veterinaria Brno · 2018 SCI-Expanded
DOÇENT KURTULUŞ PARLAK →
Matrix metalloproteinases 2 and 9 activity after intra-articular injection of autologous platelet-rich plasma for the treatment of osteoarthritis in dogs
Acta Veterinaria Brno · 2018 SCI-Expanded
DOKTOR ÖĞRETİM ÜYESİ GONCA SÖNMEZ →
Matrix metalloproteinases 2 and 9 activity after intra-articular injection of autologous platelet-rich plasma for the treatment of osteoarthritis in dogs
Acta Veterinaria Brno · 2018 SCI-Expanded
PROFESÖR MUSTAFA ARICAN →
Matrix metalloproteinases 2 and 9 activity after intra-articular injection of autologous platelet-rich plasma for the treatment of osteoarthritis in dogs
ACTA VETERINARIA BRNO · 2018 SCI-Expanded
PROFESÖR MUSTAFA ARICAN →
Matrix metalloproteinases 2 and 9 activity after intra-articular injection of autologous platelet-rich plasma for the treatment of osteoarthritis in dogs
Acta Veterinaria Brno · 2018 SCI-Expanded
PROFESÖR ATİLLA ŞİMŞEK →
Matrix metalloproteinases 2 and 9 activity after intra-articular injection of autologous platelet-rich plasma for the treatment of osteoarthritis in dogs
Acta Veterinaria Brno · 2018 SCI-Expanded
DOKTOR ÖĞRETİM ÜYESİ GONCA SÖNMEZ →
Makale Bilgileri
DergiActa Veterinaria Brno
Yayın TarihiOcak 2018
Cilt / Sayfa87 · 127-135
Scopus ID2-s2.0-85049249965
Erişim🔓 Açık Erişim
Özet
Intra-articular injection of platelet-rich plasma offers a promising potential for treatment of osteoarthritis in dogs. Twenty dogs weighing 25 to 50 kg (mean 38 kg) with unilateral stifle osteoarthritis were used for the study. Fourteen dogs were given intra-articular platelet rich plasma treatment and 6 dogs were used as controls. Double centrifuge method was used to obtain platelet-rich plasma. Radiography and ultrasonography of the affected joint were carried out and scores for lameness severity and pain severity were assigned by the attending clinicians. Synovial fluid was collected under sterile conditions at pre-treatment and on the 1st, 3rd, 5th, 7th, 15th days, and 4, 8 and 12 weeks after treatment. Gelatin zymography and Enzyme-linked Immunosorbent Assay were used to determine the synovial fluid levels of matrix metalloproteinase-2 (MMP-2) and metalloproteinase-9 (MMP-9). No adverse effects associated with the injection of the platelet concentrate or saline were observed. Hudson Visual Analog Scale and Canine Brief Pain Inventory scores for all components were non-significantly different between weeks 0, 4, 12 for control dogs. Matrix metalloproteinase-9 was totally and MMP-2 was partially inhibited in the platelet-rich plasma group. In the control group, MMP-9 was partially inhibited during the first month and activation started later. Matrix metalloproteinase-2 was constant in control samples throughout the experimental period. Platelet-rich plasma is a safe and effective method for treatment of dogs with osteoarthritis, possibly more useful for early cases with mild and moderate osteoarthritis. It is suggested that plasma rich platelet should be injected several times at regular intervals instead of a single application.
Yazarlar (5)
1
Mustafa Arican
ORCID: 0000-0001-8180-135X
2
Atilla Şimşek
3
Kurtuluş Parlak
ORCID: 0000-0002-8656-037X
4
Kamil Atli
5
Gonca Sönmez
Anahtar Kelimeler
Anti-inflammatory effect
Gelatinase
Growth factor
Lameness
Pain scores
Kurumlar
Selçuk Üniversitesi
Selçuklu Turkey
Metrikler
10
Atıf
5
Yazar
5
Anahtar Kelime